Martine Rothblatt

2017

In 2017, Martine Rothblatt earned a total compensation of $37.1M as Chairman and Chief Executive Officer at United Therapeutics, a 141% increase compared to previous year.

Compensation breakdown

Change in Pension Value and Nonqualified Deferred Compensation Earnings$1,239,653
Non-Equity Incentive Plan$1,598,163
Option Awards$33,122,078
Salary$1,163,707
Other$9,600
Total$37,133,201

Rothblatt received $33.1M in option awards, accounting for 89.20% of the total pay in 2017.

Rothblatt also received $1.2M of change in pension value and nonqualified deferred compensation earnings, $1.6M in non-equity incentive plan, $1.2M in salary and $9.6K in other compensation.

Overall ranking

Ranking

42

out of 13,853
Percentile100th

Martine Rothblatt's 2017 compensation ranked 42nd out of 13,853 executive pay records tracked by us this year.

Rothblatt earned more than 99.7% of all executives tracked by us in 2017.

Ranking in industry group

Industry groupDrugs
Ranking

2

out of 1,584
Percentile100th

In the industry group of Drugs, Rothblatt's pay ranked 2nd out of 1,584 executive pay records tracked by us in 2017.

Rothblatt earned more than 99.9% of executives in this group.

Source: SEC filing on April 27, 2018.

Rothblatt's colleagues

We found three more compensation records of executives who worked with Martine Rothblatt at United Therapeutics in 2017.

2017

Paul Mahon

United Therapeutics

General Counsel

2017

Michael Benkowitz

United Therapeutics

Chief Operating Officer

2017

James Edgemond

United Therapeutics

Chief Financial Officer

News

In-depth

You may also like